Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer

NCT00617188 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Fulvestrant

Sponsor

Masonic Cancer Center, University of Minnesota